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OBJECTIVE: To evaluate the accuracy and diagnostic
value of genome-wide noninvasive prenatal testing
(NIPT) for the detection of fetal aneuploidies in multiple
gestations, with a focus on dichorionic–diamniotic twin
pregnancies.
METHODS: We performed a retrospective cohort study
including data from pregnant women with a twin or
higher-order gestation who underwent genome-wide
NIPT at one of the eight Belgian genetic centers between
November 1, 2013, and March 1, 2020. Chorionicity and
amnionicity were determined by ultrasonography.
Follow-up invasive testing was carried out in the event
of positive NIPT results. Sensitivity and specificity were
calculated for the detection of trisomy 21, 18, and 13 in
the dichorionic–diamniotic twin cohort.
RESULTS: Unique NIPT analyses were performed for
4,150 pregnant women with a multiple gestation and
an additional 767 with vanishing gestations. The failure
rate in multiple gestations excluding vanishing gestations
ranged from 0% to 11.7% among the different genetic
centers. Overall, the failure rate was 4.8%, which could
be reduced to 1.2% after single resampling. There were
no common fetal trisomies detected among the 86
monochorionic–monoamniotic and 25 triplet cases.
Two monochorionic–diamniotic twins had an NIPT result
indicative of a trisomy 21, which was confirmed in both
fetuses. Among 2,716 dichorionic–diamniotic twin gesta-
tions, a sensitivity of 100% (95% CI 74.12–100%) and a
specificity of 100% (95% CI 99.86–100%) was reached for
trisomy 21 (n512). For trisomy 18 (n53), the respective
values were 75% (95% CI 30.06–95.44%) sensitivity and
100% (95% CI 99.86–100%) specificity, and for trisomy 13
(n52), 100% (95% CI 20.65–100%) sensitivity and 99.96%
(95% CI 99.79–99.99%) specificity. In the vanishing ges-
tation group, 28 NIPT results were positive for trisomy 21,
18, or 13, with only five confirmed trisomies.
CONCLUSION: Genome-wide NIPT performed accu-




From the Department of Human Genetics, Katholieke Universiteit Leuven,
Leuven, the Center for Human Genetics and the Department of Obstetrics and
Gynecology, Universitair Ziekenhuis Leuven, Leuven, the Center for Medical
Genetics, Universitair Ziekenhuis Gent, Ghent, the Center for Medical Genetics,
Universitair Ziekenhuis Antwerpen, Antwerp, the Center for Medical Genetics,
Universiteit Antwerpen, Antwerp, the Center for Medical Genetics, Centre
Hospitalier Universitaire de Liège, Liège, the Center for Human Genetics, Uni-
versité Libre de Bruxelles, Brussels, the Center for Human Genetics, Université
Catholique de Louvain, Brussels, the Center for Medical Genetics, Institut de
Pathologie et de Génétique Gosselies, Charleroi, the Center for Medical Genetics,
Vrije Universiteit Brussel, Brussels, and the Department of Obstetrics, Women’s
Clinic, Universitair Ziekenhuis Gent, Ghent, Belgium.
Margot van Riel is supported by a Strategic Basic Research grant of the Research
Foundation Flanders (FWO, 1S10119N).
The authors have confirmed compliance with the journal’s requirements for
authorship.
Corresponding author: Katrien Janssens, PhD, Center for Medical Genetics,
Universiteit Antwerpen, Antwerp, Belgium; email: katrien.janssens@
uantwerpen.be.
Financial Disclosure
The authors did not report any potential conflicts of interest.
© 2021 by the American College of Obstetricians and Gynecologists. Published
by Wolters Kluwer Health, Inc. All rights reserved.
ISSN: 0029-7844/21
© 2021 by the American College of Obstetricians
and Gynecologists. Published by Wolters Kluwer Health, Inc.
Unauthorized reproduction of this article is prohibited.
1102 VOL. 137, NO. 6, JUNE 2021 OBSTETRICS & GYNECOLOGY
Noninvasive prenatal testing (NIPT) is widelyimplemented into clinical care as a first-tier
screening test. A meta-analysis on the performance
of cell-free DNA screening in singleton pregnancies
reported a weighted pooled sensitivity of 99.7% and
a false-positive rate of 0.04% for the detection of
fetal trisomy 21.1
In twin pregnancies, however, detailed informa-
tion on the performance of NIPT is limited and there
are several factors that make it more challenging.
Although the total fetal fraction is higher in twin
pregnancies, the contribution of cell-free DNA from
each twin is lower.2 Moreover, the contribution per
fetus can be different, potentially varying by as much
as twofold.3 In addition, chorionicity has important
implications for the accuracy of NIPT in twin preg-
nancies.4 In dizygotic twins, each twin has its own
placenta contributing to the circulating cell-free
DNA, resulting in a discordant aneuploidy risk for
both fetuses.5
Given the implementation challenges, and the
lack of sufficient validation data related to the
accuracy of NIPT in twin pregnancies, uniform
recommendations are not available.6–9 Nevertheless,
an accurate NIPT for twin pregnancies is highly
desired, as the accuracy of combined nuchal translu-
cency and first trimester serum screening is limited in
twin gestations, with a pooled sensitivity of 89.3% and
a pooled specificity of 94.6% for the detection of tri-
somy 21.10
Our objective was to evaluate the accuracy and
diagnostic value of genome-wide NIPT for the detec-
tion of fetal aneuploidies in multiple gestations, with a
specific focus on dichorionic–diamniotic twins. We
hypothesized that NIPT in multiple gestations, includ-
ing dichorionic–diamniotic twins, would show high
sensitivity and specificity for detection of aneuploidy.
METHODS
This was a retrospective cohort study of pregnant
women with a multiple gestation having undergone
NIPT at the clinical laboratories of one of the eight
Belgian genetic centers (Katholieke Universiteit
Leuven, Universitair Ziekenhuis Antwerpen, Univer-
sitair Ziekenhuis Gent, Vrije Universiteit Brussel,
Université Libre de Bruxelles, Centre Hospitalier
Universitaire de Liège, Université Catholique de Lou-
vain, and l’Institut de Pathologie et de Génétique).
These genetic centers perform all invasive prenatal
and neonatal genetic testing in Belgium. Genetic
counseling was provided by obstetricians before
blood sampling for NIPT and consent for clinical test-
ing was obtained. Contraindications for NIPT testing
were ultrasonogram abnormalities (including a nuchal
translucency measurement exceeding 3.5 mm), or a
history of stem cell, organ, or tissue transplant. Periph-
eral blood samples were collected from pregnant
women from 10 weeks of gestation onward in Cell-
Free DNA BCT tubes, Cell-Free DNA collection
tubes, or PAXgene Blood ccfDNA tubes. Plasma iso-
lation was carried out using standard centrifugation
techniques and methods for cell-free DNA extraction,
library preparation, whole genome sequencing, and
analysis were carried out by the different genetic cen-
ters as described in Appendix 1, available online at
http://links.lww.com/AOG/C291.
Twin chorionicity and amnionicity were evalu-
ated by ultrasonography to classify twin pregnancies
as dichorionic–diamniotic, monochorionic–diamni-
otic, or monochorionic–monoamniotic. A vanishing
twin was defined as a spontaneous reduction of a fetus
in utero. In cases of a dichorionic–diamniotic twin
pregnancy, parents were informed that the test accu-
racy for aneuploidy could be lower as compared with
monochorionic twin pregnancies. Both common fetal
aneuploidies (aneuploidies of chromosome 13, 18, or
21) and rare autosomal trisomies detected by NIPT
were reported to the parents for further follow-up.
Fetal sex chromosome aneuploidies were not reported
per clinical protocol.
If NIPT was positive for a chromosomal abnor-
mality, pregnant women were offered follow-up by
standard invasive prenatal diagnosis based on DNA
preferably extracted from amniotic fluid. Analysis
was carried out using the Agilent ISCA 60K or 44K
array, the CytoSure v3 microarray, the Cytoscan
750K, the HumanCytoSNP-12 v2.1 BeadChip, or
by shallow whole genome sequencing.11 Testing for
the presence of a uniparental disomy was carried
out when applicable (nonverified trisomy of chro-
mosome 6, 7, 11, 14, 15, or 20) by polymorphic
short tandem repeat analysis, by use of the Human-
CytoSNP-12 v2.1 BeadChip, or by methylation-
specific multiplex ligation-dependent probe ampli-
fication using the SALSA MLPA Probemix ME034-
A1. In the event of a technical failure or an incon-
clusive result, blood sampling and NIPT analysis
were repeated.
Pregnancy outcomes, including false-negative
cases, were retrieved from the clinical databases
available in each genetic center. Because all prenatal
and neonatal cytogenetic testing in Belgium is per-
formed in one of the genetic centers involved in this
study, it is very unlikely that a false-negative case was
missed. Data were analyzed using R studio 1.3.959
and Excel 16.41. Test performance was expressed as
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sensitivity, specificity, and positive and negative
likelihood ratios. CIs were calculated using the New-
combe12-Wilson method without continuity correc-
tion. Chi-squared tests were used to compare
percentages, with P,.05 considered statistically
significant.
This study was approved by the Ethics Commit-
tee of the University Hospital of Antwerp.
RESULTS
We included 4,150 unique NIPT analyses in women
with a multiple gestation and 767 in women with a
vanishing gestation between November 1, 2013, and
March 1, 2020. Among the multiple gestations, 2,716
(65.4%) were dichorionic–diamniotic twins, 790
(19.0%) monochorionic–diamniotic twins, 86 (2.1%)
monochorionic–monoamniotic twins, eight (0.2%)
monochorionic unspecified, and 25 (0.6%) triplets
(Appendix 2, available online at http://links.lww.
com/AOG/C291). For 525 (12.7%) twins, information
on chorionicity, amnionicity, or both was unavailable.
Of the 767 vanishing gestations, 13 were dichorionic–
diamniotic twins originating from a triplet with one
vanishing gestation, and seven were triplets with dou-
ble vanishing gestations. Also, four quadruplets with
double (n53) or triple (n51) vanishing gestations
were included.
In this multicenter study, a large variation in
failure rate was detected across centers, ranging from
0% to 11.7% in multiple gestations, excluding vanish-
ing gestations. Overall, for 4.8% (n5198) of all multi-
ple gestation samples excluding vanishing gestations,
no result was obtained on the first analysis. After a
single resampling, a conclusive result could be ob-
tained for 4,101 out of 4,150 cases, resulting in an
overall success rate of 98.8% for multiple gestations.
Reasons for failure included low fetal fraction, poor
quality, or a combination of both. In vanishing gesta-
tions, the failure rate was higher with 48 test failures
out of 767 analyses (6.3%) after first sampling. After a
second sampling, the success rate increased to 99.4%.
Noninvasive prenatal testing was positive for one
of the common fetal trisomies in 17 (0.63%) of the
dichorionic–diamniotic twins (Fig. 1). Twelve (0.44%)
dichorionic–diamniotic cases had an NIPT result pos-
itive for trisomy 21, three (0.11%) for trisomy 18, and
two (0.07%) for trisomy 13. Confirmatory invasive
genetic testing results were available for all but one
trisomy 21 case. Amniocentesis confirmed the trisomy
in 14 cases; for one trisomy 21 case no amniocentesis
Fig. 1. Reported trisomies subdivided by twin category and by outcome of invasive follow-up. Chromosomes with zero
trisomy cases were left out. *In one twin with unspecified amnionicity or chorionicity, trisomy 21 was detected by non-
invasive prenatal testing and confirmed by amniocentesis in both twins. DCDA, dichorionic–diamniotic; MCDA, mono-
chorionic–diamniotic; vanishing, vanishing twin.
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was performed, but chorionic villous sampling con-
firmed the trisomy, and an increased nuchal translu-
cency was detected by ultrasonography on which
selective feticide was performed. The remaining case,
with a positive NIPT for trisomy 13 that was not con-
firmed by amniocentesis, had no placental follow-up
to evaluate for confined placental mosaicism. In all
but one of the cases where the trisomy was confirmed
by amniocentesis, the trisomy was restricted to one
twin; in one trisomy 18 case, both twins were affected.
In one dichorionic–diamniotic twin with trisomy 21,
the other twin was triploid.
Two of 790 monochorionic–diamniotic twins had
a NIPT result positive for trisomy 21. In both cases,
trisomy 21 was confirmed in the two fetuses. In one
twin with unspecified amnionicity or chorionicity, tri-
somy 21 was detected by NIPT and confirmed by
amniocentesis in both fetuses. There were no com-
mon fetal trisomies detected among the 86 monochor-
ionic–monoamniotic and 25 triplet cases.
In 767 vanishing gestation pregnancies, NIPT
detected a common trisomy in 28 cases (3.65%).
Nineteen cases were positive for trisomy 21, of
which three were confirmed in the remaining fetus
and one in the deceased fetus. There were four
trisomy 18 cases, of which one was confirmed in the
deceased fetus. In five cases, NIPT was positive for
trisomy 13, including one case that had a positive
NIPT result for trisomy 7 as well. One trisomy 13,
one trisomy 18, and three trisomy 21 cases were lost
to follow-up. The other 18 cases (12 with trisomy
21, two with trisomy 18, and four with trisomy 13)
were not confirmed, but in all these cases only the
remaining fetus was tested.
Overall, 36 rare autosomal trisomies were de-
tected by the genome-wide NIPT analyses (Fig. 1).
The majority of rare autosomal trisomies were de-
tected in vanishing gestations (n523), including one
triplet with a vanishing gestation, leading to an mono-
chorionic–monoamniotic twin gestation. In vanishing
gestations, single cases of trisomy 4, 8, 9, 12, and 20
were detected. Furthermore, four cases with trisomy 7
were detected, including one case that was positive for
both trisomy 7 and trisomy 13, as mentioned earlier.
Additionally, four cases were positive for trisomy 16,
four for trisomy 22, and six cases were positive for
trisomy 15. Confirmatory invasive testing was avail-
able for 20 of the 23 vanishing gestation cases and
showed that none of the rare autosomal trisomies
could be confirmed in fetal tissue. Additionally, eight
dichorionic–diamniotic twins were detected to have a
rare autosomal trisomy. Five cases were positive for
trisomy 7, two for trisomy 8, and one for trisomy 16.
Invasive testing by amniocentesis failed to confirm an
aneuploidy in four of these, and the other four were
lost to follow-up. Lastly, NIPT detected a rare autoso-
mal trisomy in five monochorionic–diamniotic twins.
Two monochorionic–diamniotic twins were positive
for trisomy 7 with one not confirmed by amniocente-
sis and one lost to follow-up. One monochorionic–
diamniotic twin had an NIPT positive for trisomy
14, which was not confirmed by amniocentesis, and
in two other monochorionic–diamniotic twins a tri-
somy 20 was detected, which were both not confirmed
by amniocentesis. No rare autosomal trisomies were
detected in monochorionic–monoamniotic twins or in
triplet pregnancies.
According to Belgian guidelines, rare autosomal
trisomies are communicated to the pregnant woman,
stating the possibility of confined placental mosaicism,
and ultrasonography and invasive follow-up are
recommended.13 In cases of confined placental mosa-
icism, analysis of uniparental disomy on amniotic
fluid is warranted for chromosomes 6, 7, 11, 14, 15,
and 20 because of their association with developmen-
tal disorders.13,14 In our cohort, results of uniparental
disomy analysis were available for eight cases; all
were uniparental disomy negative.
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The rate of both common fetal trisomies (3.7% vs
0.6%) and rare autosomal trisomies (3.0% vs 0.3%)
was higher in vanishing gestations as compared with
the dichorionic–diamniotic cohort (P,.001 for both
comparisons).
Only one false-negative NIPT result was reported
in a dichorionic–diamniotic twin gestation, in which
fetal ultrasonography later in pregnancy detected
structural anomalies. Amniocentesis was performed
to confirm a diagnosis of trisomy 18 in one of the
fetuses.
In five vanishing gestation cases, as well as in one
quadruplet pregnancy with two vanishing gestations,
the fetal sex detected with NIPT did not match the sex
observed on ultrasonogram of the remaining fetus. In
all six of these cases, NIPT detected a male fetus but
the surviving twin was female.
Test characteristics for monochorionic–diamni-
otic, monochorionic–monoamniotic, and triplet preg-
nancies could not be calculated owing to low
frequency of aneuploidies in those groups. Sensitivity
and specificity for the detection of common aneu-
ploidies in dichorionic–diamniotic twin gestations
were both high (Table 1).
DISCUSSION
Studies on the accuracy of NIPT in twin pregnancies
are limited and include relatively small numbers.2,15–23
This study reports on one of the largest cohorts of
women with a twin gestation undergoing screening
for aneuploidy with NIPT, and demonstrates high sen-
sitivity and specificity for detection of trisomy 21 in
dichorionic–diamniotic twins.
For the common trisomies, there was only one
false-positive dichorionic–diamniotic case. Confined
placental mosaicism, previously demonstrated as a
main cause of false-positive NIPT results in the gen-
eral population,24–26 could be the explanation for this
false-positive result, but placental analysis was not per-
formed for confirmation.
Noninvasive prenatal testing detected 12 (0.44%)
trisomy 21 cases, three (0.11%) trisomy 18 cases, and
two (0.07%) trisomy 13 cases in our dichorionic–dia-
mniotic group. These incidences are comparable with
those in the general population.27,28 Twin pregnancies
are historically believed to have a higher aneuploidy
risk than singleton pregnancies because of a higher
mean maternal age and because in a dizygotic preg-
nancy, each fetus has an individual aneuploidy risk.
However, risks were mainly calculated based on sta-
tistical models rather than real data sets and observa-
tional data now suggest a lower birth prevalence of
trisomy 21 than expected29,30; this is confirmed in our
data set.
In this study, which includes NIPT results of
one of the largest vanishing gestation cohorts
described to date,31,32 NIPT detected a higher per-
centage of both common and rare autosomal triso-
mies when compared with the dichorionic–
diamniotic cohort. Chromosomal abnormalities
are a major cause for spontaneous abortion as they
are found in about half of evaluated products of
conception.33 Several cases of common fetal triso-
mies and all rare autosomal trisomies remained
unconfirmed in our vanishing gestation cohort. In
most cases, only the remaining fetus could be tested,
and the trisomy result was suspected to originate
from the deceased fetus. For one trisomy 18 case
and one trisomy 21 case, the trisomy could indeed
be traced to the deceased twin. False-positive results
and sex discrepancies in vanishing twin pregnancies
are a well-known problem due to skewing of the
NIPT profiles by the cell-free DNA of the deceased
twin15,16,31,32 and should be discussed during
genetic counseling. In case of a normal NIPT result,
follow-up is the same as in singleton gestations.
When NIPT demonstrates an increased risk of aneu-
ploidy, invasive testing is offered to exclude the
presence of the aneuploidy in the remaining twin.
In our opinion, NIPT is useful in case of a vanishing
gestation because it might reveal the cause of death
of the vanishing gestation and indicate the need for
ultrasonography follow-up of the remaining fetus.
Ninety-seven percent of all rare autosomal tri-
somies detected in chorionic villus samples can be
explained by confined placental mosaicism24–26; a
similar percentage is expected for NIPT samples. In
our dichorionic–diamniotic cohort, none of the rare
autosomal trisomies were confirmed, but the sus-
pected association between a rare autosomal trisomy
and an adverse pregnancy outcome warrants further
close surveillance of the pregnancy.34 Moreover, con-
fined placental mosaicism poses a (small) risk for uni-
parental disomy, and testing is currently advised for
chromosomes carrying imprinted regions.13 Unipa-
rental disomy data were available from two dichor-
ionic–diamniotic twins where NIPT detected a
trisomy 7; both were negative.
Large differences in the failure rate of NIPT in
twin pregnancies have been reported, ranging from
0.5% to 13.2% after first sampling.17,35–37 Likewise,
this multicenter study shows a wide range in failure
rate (0–11.7%). We obtained a result in all but 4.8% of
multiple gestation samples excluding vanishing twins;
this could be reduced to 1.2% after resampling. The
© 2021 by the American College of Obstetricians
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large differences in failure rate might be explained by
variability in the threshold for fetal fraction set by the
different genetic centers.
Few labs have performed NIPT in triplets and
higher-order multiples, as large data sets are difficult
to collect. Correct interpretation of NIPT and accu-
rate determination of fetal sex seem achievable in
triplet pregnancies,2,21 as demonstrated in our cohort
of 25 triplets, but more studies with larger cohorts and
positive cases are required. In our opinion, NIPT
would be a valuable screening option for higher-
order multiples, because maternal serum markers can-
not be applied and current screening is based on ultra-
sonography and maternal age only.5,21
Our results indicate excellent test performance of
NIPT for detection of aneuploidy in one of the largest
twin cohorts. However, we acknowledge the impor-
tance of ultrasonogram examinations to determine
chorionicity and detect structural defects. Also, a
positive NIPT result should always be confirmed by
invasive testing, preferably by amniocentesis to rule
out confined placental mosaicism. Given that the
Belgian genetic centers involved in this study perform
all invasive prenatal genetic testing and all neonatal
testing in Belgium, complete follow-up of all positive
NIPT results is ensured, allowing us to determine the
false-positive cases, and optimal tracing of false-
negative cases. Limitations of this study include the
relatively low number of trisomy 13 and trisomy 18
cases. In addition, the different whole genome anal-
ysis methods used varied among centers, including
the presence of different cutoffs for fetal fraction.
However, this may increase generalizability of the
results to other centers.
In conclusion, we demonstrate that genome-wide
NIPT analysis is an accurate screening tool for
common fetal trisomies in dichorionic–diamniotic
twin gestations, and improves pregnancy manage-
ment as current screening options, combined nuchal
translucency measurement and first trimester serum
screening, have limited sensitivity and specificity in
multiple gestations.
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